Moving forward with Metronomic Chemotherapy: Meting report of the 2nd International workshop on Metronomic and Anti-Angiodenic chemotherapy in Pediatric Oncology.

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F11%3A%230001227" target="_blank" >RIV/65269705:_____/11:#0001227 - isvavai.cz</a>

Result on the web

<a href="http://dx.doi.org/10.1593/tlo.11124" target="_blank" >http://dx.doi.org/10.1593/tlo.11124</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1593/tlo.11124" target="_blank" >10.1593/tlo.11124</a>

Result language

angličtina

Original language name

Moving forward with Metronomic Chemotherapy: Meting report of the 2nd International workshop on Metronomic and Anti-Angiodenic chemotherapy in Pediatric Oncology.

Original language description

Metronomic chemotherapy, which is defined by the frequent, repetitive administration of chemotherapeutic drugs at relatively low doses, and without prolonged drug-free break, is an emerging strategy to fight cancer. Initially thought to act by targetingtumor angiogenesis, additional mechanisms have been recently unveiled, and metronomic chemotherapy is now considered to represent a form of multitargeted therapy. Despite representing a genuine alternative for advanced and/or high-risk cancer therapy, the development of metronomic approaches in pediatric oncology still in the early stage. The few numbers of large-scale state-of-the-art clinical trials, issues regarding terminology and the limited understanding of the complex and intertwined mechanisms of action of metronomic treatments have limited progress in this important field of research. On March 18 and 19, 2010, the 2nd International Workshop on Metronomic and Anti-Angiogenic Chemotherapy in Paediatric Oncology was held in Marsei

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FD - Oncology and haematology

OECD FORD branch

—

Project

—

Continuities

N - Vyzkumna aktivita podporovana z neverejnych zdroju

Publication year

2011

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Translational Oncology

ISSN

1936-5233

e-ISSN

—

Volume of the periodical

4

Issue of the periodical within the volume

4

Country of publishing house

US - UNITED STATES

Number of pages

9

Pages from-to

189-197

UT code for WoS article

000294253200001

EID of the result in the Scopus database

—